Business Description
Can Fite Biofarma Ltd
ISIN : IL0010944739
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 155.66 | |||||
Equity-to-Asset | 0.57 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.01 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -24.1 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -64.2 | |||||
3-Year EBITDA Growth Rate | 55.3 | |||||
3-Year EPS without NRI Growth Rate | 58.5 | |||||
3-Year FCF Growth Rate | 53.1 | |||||
3-Year Book Growth Rate | -35.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 94.78 | |||||
9-Day RSI | 81.02 | |||||
14-Day RSI | 70.38 | |||||
6-1 Month Momentum % | -23.53 | |||||
12-1 Month Momentum % | -7.14 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.1 | |||||
Quick Ratio | 4.1 | |||||
Cash Ratio | 3.59 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -89.1 | |||||
Shareholder Yield % | 0.3 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -1203.29 | |||||
Net Margin % | -1146.78 | |||||
FCF Margin % | -1377.09 | |||||
ROE % | -138.46 | |||||
ROA % | -80.83 | |||||
ROIC % | -897.34 | |||||
ROC (Joel Greenblatt) % | -7805.97 | |||||
ROCE % | -109.7 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 7 | |||||
PB Ratio | 1.75 | |||||
Price-to-Tangible-Book | 1.4 | |||||
EV-to-EBIT | -0.64 | |||||
EV-to-EBITDA | -0.64 | |||||
EV-to-Revenue | 7.65 | |||||
EV-to-Forward-Revenue | 1.21 | |||||
EV-to-FCF | -0.55 | |||||
Price-to-Net-Current-Asset-Value | 1.4 | |||||
Price-to-Net-Cash | 2.8 | |||||
Earnings Yield (Greenblatt) % | -156.25 | |||||
FCF Yield % | -78.06 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Can Fite Biofarma Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₪) | 2.876 | ||
EPS (TTM) (₪) | -0.018 | ||
Beta | 0 | ||
Volatility % | 62.2 | ||
14-Day RSI | 70.38 | ||
14-Day ATR (₪) | 0.001306 | ||
20-Day SMA (₪) | 0.027 | ||
12-1 Month Momentum % | -7.14 | ||
52-Week Range (₪) | 0.021 - 0.041 | ||
Shares Outstanding (Mil) | 1,813.93 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Can Fite Biofarma Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Can Fite Biofarma Ltd Stock Events
Event | Date | Price(₪) | ||
---|---|---|---|---|
No Event Data |
Can Fite Biofarma Ltd Frequently Asked Questions
What is Can Fite Biofarma Ltd(XTAE:CANF)'s stock price today?
When is next earnings date of Can Fite Biofarma Ltd(XTAE:CANF)?
Does Can Fite Biofarma Ltd(XTAE:CANF) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |